Government-Backed Biotech: Why Soligenix (SNGX) Deserves a Closer Look
Soligenix, Inc. (NASDAQ: SNGX) has been gaining investor attention as a late-stage biopharmaceutical company focused on developing and commercializing treatments across oncology, rare diseases, and biodefense. For small-cap investors, SNGX stands out because of its pipeline maturity and government partnerships, both of which can serve as strong catalysts for long-term value creation.